FDA’s Oversight of Digital Health Products and Medical Software
The US Food and Drug Administration (FDA) regulates many digital health products such as wearables, medical apps, and software that use technologies including artificial intelligence (AI)/machine learning (ML) to help patients manage their diseases and to help physicians diagnose and treat them. Depending on its use, a product may be subject to minimal or no FDA regulation while others may require FDA clearance prior to marketing. Find out more about how FDA regulates digital health products so you can adjust your business strategy accordingly.
Please join Harvard Club of Dallas and the Harvard Business School Club of Dallas, as well as members of Holland & Knight's Digital Healthcare Group, for a panel discussion on how the FDA regulates digital health products and tips on how you can adjust your business strategy accordingly.
Date: July 14, 2021
Time: 12 - 1:00pm
Location: Zoom. Details on how to join the discussion will be emailed to all registered guests by Wednesday, July 14, 2021 at 9am.
Cost: There is no cost to attend, but an RSVP is required. Click here to RSVP.